Search Results

The Premier Platinum HpSA enzyme immunoassay (EIA) is an in vitro qualitative procedure for the detection of Helicobacter pylori antigens in human stool. Test results are intended to aid in the diagnosis of H. pylori infection, and to monitor response during and post-therapy in adult patients. Accepted medical practice recommends that testing by any current method, to confirm eradication, be done at least four weeks following completion of therapy.

The Premier Platinum HpSA test utilizes polyclonal anti-H. pvlori capture antibody adsorbed to microwells. Diluted patient samples and a peroxidase conjugated polyclonal antibody are added to the wells and incubated for one hour at room temperature. A wash is performed to remove unbound material. Substrate is added and incubated for ten minutes at room temperature. Color develops in the presence of bound enzyme. Stop solution is added and the results are interpreted visually or spectrophotometrically.

Here's an analysis of the provided text, focusing on the acceptance criteria and study details for the Premier Platinum HpSA device:

1. Table of Acceptance Criteria and Reported Device Performance

The document doesn't explicitly state "acceptance criteria" in a numerical target format for the Premier Platinum HpSA device itself. Instead, it justifies substantial equivalence by comparing its performance against a predicate device (Meretek UBT). The acceptance is implied by the comparable or superior performance relative to the predicate.

Here's a table comparing the Premier Platinum HpSA's performance to its predicate:

2. Sample Size Used for the Test Set and Data Provenance

The document does not explicitly state the sample size used for the test set during the performance validation. It provides confidence intervals for Sensitivity, Specificity, and Correlation for both the Premier Platinum HpSA and the predicate device, which implies a certain sample size was used to achieve those intervals, but the exact number is not given.

The data provenance (country of origin, retrospective/prospective) is also not specified in the provided text.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

The document does not specify the number of experts used or their qualifications to establish the ground truth for the test set.

4. Adjudication Method for the Test Set

The document does not specify the adjudication method used for the test set.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This device is an in-vitro diagnostic test for detecting H. pylori antigens in stool, interpreted visually or spectrophotometrically, not an imaging device requiring human reader interpretation in the same way an MRMC study would apply. The comparison is between two diagnostic assays, not between human readers with and without AI assistance.

6. Standalone Performance Study

Yes, a standalone performance study was done. The reported Sensitivity, Specificity, and Correlation for the Premier Platinum HpSA (94.7%, 96.1%, and 95.8% respectively) represent the standalone performance of the algorithm/assay itself.

7. Type of Ground Truth Used

The document states "Performance vs. Reference Methods" when presenting the sensitivity, specificity, and correlation. While not explicitly defined, "Reference Methods" in the context of diagnostic tests typically refer to established, highly accurate diagnostic tests or a combination of clinical outcomes and other diagnostic modalities (e.g., histology/pathology, culture, or a consensus of multiple established clinical tests). Given this is a diagnostic test for H. pylori, common reference methods include histology, culture, or other validated breath tests/serology in combination with clinical presentation.

8. Sample Size for the Training Set

The document does not provide any information about a "training set" or its sample size. This is typical for traditional in-vitro diagnostic (IVD) assays developed without machine learning or AI components in the modern sense. The "training" and optimization of such assays usually refer to laboratory development and optimization steps, not a distinct "training set" for an algorithm.

9. How the Ground Truth for the Training Set Was Established

As no training set is mentioned (see point 8), there is no information on how its ground truth was established.

Ask a specific question about this device